These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 16416279)

  • 1. A multicenter reproducibility study of single-voxel 1H-MRS of the medial temporal lobe.
    Träber F; Block W; Freymann N; Gür O; Kucinski T; Hammen T; Ende G; Pilatus U; Hampel H; Schild HH; Heun R; Jessen F
    Eur Radiol; 2006 May; 16(5):1096-103. PubMed ID: 16416279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
    Frederick BD; Lyoo IK; Satlin A; Ahn KH; Kim MJ; Yurgelun-Todd DA; Cohen BM; Renshaw PF
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1313-22. PubMed ID: 15588758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction in temporal N-acetylaspartate and creatine (or choline) ratio in temporal lobe epilepsy: does this 1H-magnetic resonance spectroscopy finding mean poor seizure control?
    Mendes-Ribeiro JA; Soares R; Simões-Ribeiro F; Guimarães ML
    J Neurol Neurosurg Psychiatry; 1998 Oct; 65(4):518-22. PubMed ID: 9771777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amino acid metabolic processes in the temporal lobes assessed by proton magnetic resonance spectroscopy (1H MRS) in children with Down syndrome.
    Śmigielska-Kuzia J; Boćkowski L; Sobaniec W; Kułak W; Sendrowski K
    Pharmacol Rep; 2010; 62(6):1070-7. PubMed ID: 21273664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study of the different N-acetylaspartate measures of the medial temporal lobe in Alzheimer's disease.
    Jessen F; Traeber F; Freymann N; Maier W; Schild HH; Heun R; Block W
    Dement Geriatr Cogn Disord; 2005; 20(2-3):178-83. PubMed ID: 16024934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton MR spectroscopy detects a relative decrease of N-acetylaspartate in the medial temporal lobe of patients with AD.
    Jessen F; Block W; Träber F; Keller E; Flacke S; Papassotiropoulos A; Lamerichs R; Heun R; Schild HH
    Neurology; 2000 Sep; 55(5):684-8. PubMed ID: 10980734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the diagnostic utility on 1.5T and 3.0T
    Qu B; Tan H; Xiao M; Liu D; Wang S; Zhang Y; Chen R; Zheng G; Yang Y; Yan G; Qu X
    BMC Med Imaging; 2023 Nov; 23(1):185. PubMed ID: 37964218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anterior to posterior hippocampal MRS metabolite difference is mainly a partial volume effect.
    Starck G; Vkhoff-Baaz B; Ljungberg M; Malmgren K; Forssell-Aronsson E; Jönsson L; Ekholm S
    Acta Radiol; 2010 Apr; 51(3):351-9. PubMed ID: 20201639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reproducibility of short echo time proton magnetic resonance spectroscopy using point-resolved spatially localized spectroscopy sequence in normal human brains.
    Hoshino Y; Yoshikawa K; Inoue Y; Asai S; Nakamura T; Ogino T; Umeda M; Iwamoto A
    Radiat Med; 1999; 17(2):115-20. PubMed ID: 10399778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton MR spectroscopy of cerebellitis.
    Guerrini L; Belli G; Cellerini M; Nencini P; Mascalchi M
    Magn Reson Imaging; 2002 Oct; 20(8):619-22. PubMed ID: 12467871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal pole proton preoperative magnetic resonance spectroscopy in patients undergoing surgery for mesial temporal sclerosis.
    Fountas KN; Tsougos I; Gotsis ED; Giannakodimos S; Smith JR; Kapsalaki EZ
    Neurosurg Focus; 2012 Mar; 32(3):E3. PubMed ID: 22380857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance spectroscopy performance for detection of dementia, Alzheimer's disease and mild cognitive impairment in a community-based survey.
    García Santos JM; Gavrila D; Antúnez C; Tormo MJ; Salmerón D; Carles R; Jiménez Veiga J; Parrilla G; Torres del Río S; Fortuna L; Navarro C
    Dement Geriatr Cogn Disord; 2008; 26(1):15-25. PubMed ID: 18566544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A short-echo-time proton magnetic resonance spectroscopic imaging study of temporal lobe epilepsy.
    Simister RJ; Woermann FG; McLean MA; Bartlett PA; Barker GJ; Duncan JS
    Epilepsia; 2002 Sep; 43(9):1021-31. PubMed ID: 12199727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative multivoxel proton MR spectroscopy study of brain metabolites in patients with amnestic mild cognitive impairment: a pilot study.
    Yang ZX; Huo SS; Cheng XF; Xu ZF; Cao Z; Zeng JX; Xiao YY; You KZ; Chen W; Liu YY; Wu RH
    Neuroradiology; 2012 May; 54(5):451-8. PubMed ID: 21739221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative proton MR spectroscopic imaging of the mesial temporal lobe.
    Arslanoglu A; Bonekamp D; Barker PB; Horská A
    J Magn Reson Imaging; 2004 Nov; 20(5):772-8. PubMed ID: 15503328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-voxel long TE 1H-MR spectroscopy of the normal brainstem and cerebellum.
    Mascalchi M; Brugnoli R; Guerrini L; Belli G; Nistri M; Politi LS; Gavazzi C; Lolli F; Argenti G; Villari N
    J Magn Reson Imaging; 2002 Nov; 16(5):532-7. PubMed ID: 12412029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serial precision of metabolite peak area ratios and water referenced metabolite peak areas in proton MR spectroscopy of the human brain.
    Simmons A; Smail M; Moore E; Williams SC
    Magn Reson Imaging; 1998 Apr; 16(3):319-30. PubMed ID: 9621973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton magnetic resonance spectroscopy in dementia of Alzheimer type.
    Heun R; Schlegel S; Graf-Morgenstern M; Tintera J; Gawehn J; Stoeter P
    Int J Geriatr Psychiatry; 1997 Mar; 12(3):349-58. PubMed ID: 9152720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of reproducibility of single voxel spectroscopy and whole-brain magnetic resonance spectroscopy imaging at 3T.
    Zhang Y; Taub E; Salibi N; Uswatte G; Maudsley AA; Sheriff S; Womble B; Mark VW; Knight DC
    NMR Biomed; 2018 Apr; 31(4):e3898. PubMed ID: 29436038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-acetylaspartate, choline, myoinositol, glutamine and glutamate (glx) concentration changes in proton MR spectroscopy (1H MRS) in patients with mild cognitive impairment (MCI).
    Walecki J; Barcikowska M; Ćwikła JB; Gabryelewicz T
    Med Sci Monit; 2011 Dec; 17(12):MT105-11. PubMed ID: 22129910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.